Quick Takeaways
- This page summarizes Roberto Cuca's Form 4 filing for TELA Bio, Inc. (TELA).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 07 Jun 2022, 16:05.
Roberto Cuca - 07 Jun 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)
- Role
- COO and CFO
- Signature
- /s/ Megan Smeykal, Attorney-in-fact
- Issuer symbol
- TELA
- Transactions as of
- 07 Jun 2022
- Net transactions value
- +$82,500
- Form type
- 4
- Filing time
- 07 Jun 2022, 16:05:21 UTC
- Previous filing
- 25 Feb 2022
- Next filing
- 27 Feb 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Roberto Cuca filed Form 4 for TELA Bio, Inc. (TELA) on 07 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 25 Feb 2022.
- Current net transaction value: +$82,500.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
TELA
transaction
Common Stock
Purchase
- Transaction value
- $82,500
- Shares
- +15,000
- Change %
- +75%
- Price
- $5.50
- Shares after
- 34,892
- Date
- 07 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $5.28 to $5.62. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |